A conditional self-inactivating retrovirus vector that uses a tetracycline-responsive expression system

Journal of Virology

Volumn 71, Issue 9, 1997, Pages 7128-7131

  Hwang, Jung Joo ^a   Li, Ling ^a   Anderson, W French ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TETRACYCLINE; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; GENE TARGETING; LONG TERMINAL REPEAT; MOLONEY LEUKEMIA ONCOVIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; VIRUS INACTIVATION; VIRUS PARTICLE; VIRUS RECOMBINANT; VIRUS REPLICATION;

EID: 0030769369     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.9.7128-7131.1997     Document Type: Article

References (31)

1. Anderson, W. F. 1992. Human gene therapy. Science 256:808-813.
2. Bishop, J. M. 1983. Cellular oncogenes and retroviruses. Annu. Rev. Biochem. 52:301-354.
3. Dougherty, J. P., and H. M. Temin. 1987. A promoterless retroviral vector indicates that there are sequences in U3 required for 3′ RNA processing. Proc. Natl. Acad. Sci. USA 84:1197-1201.
4. Eglitis, M. A., and W. F. Anderson. 1988. Retroviral vectors for introduction of genes into mammalian cells. BioTechniques 6:608-614.
5. Emerman, M., and H. M. Temin. 1984. Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism. Cell 39:459-467.
6. Emerman, M., and H. M. Temin. 1986. Comparison of promoter expression in avian and murine retrovirus vectors. Nucleic Acids Res. 14:9381-9386.
7. Gilboa, E., M. A. Eglitis, P. W. Kantoff, and W. F. Anderson. 1986. Transfer and expression of cloned genes using retroviral vectors. BioTechniques 4: 504-512.
8. Gossen, M., and H. Bujard. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsivc promoters. Proc. Natl. Acad. Sci. USA 89:5547-5551.
9. Hawley, R. G., L. Covarrubias, T. Hawley, and B. Mintz. 1987. Handicapped retroviral vectors efficiently transduce foreign genes into hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 84:2406-2410.
10. Hawley, R. G., L. A. Sabourin, and T. S. Hawley, 1989. An improved retroviral vector for gene transfer into undifferentiated cells. Nucleic Acids Res. 17:4001.
11. Hofmann, A., G. P. Nolan, and H. M. Blau. 1996. Rapid retroviral delivery of tetracycline-inducible genes in a single autoregulatory cassette. Proc. Natl. Acad. Sci. USA 93:5185-5190.
12. Hoshimaru, M., J. Ray, D. W. Y. Sah, and F. H. Gage. 1996. Differentiation of the immortalized adult neuronal progenitor cell line HC2S2 into neurons by regulatable suppression of the v-myc oncogene. Proc. Natl. Acad. Sci. USA 93:1518-1523.
13. Hwang. J.-J., Z. Scurie, and W. F. Anderson. 1996. Novel retroviral vector transferring a suicide gene and a selectable marker gene with enhanced gene expression by using a tetracycline-responsive expression system. J. Virol. 70:8138-8141.
14. Ilda, A., S.-T. Chen, T. Friedmann, and J.-K. Yee. 1996. Inducible gene expression by retrovirus-mediated transfer of a modified tetracycline-regulated system. J. Virol. 70:6054-6059.
15. Linial, M., and M. Groudine. 1985. Transcription of three c-myc exons is enhanced in chicken bursal lymphoma cell lines. Proc. Natl. Acad. Sci. USA 82:53-57.
16. Miller, A. D. 1992. Human gene therapy comes of age. Nature 357:455-460.
17. Miller, A. D., and C. Buttimore. 1986. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol. 6:2895-2902.
18. Miller, A. D., and G. J. Rosman. 1989. Improved retroviral vectors for gene transfer and expression. BioTechniques 7:980-990.
19. Olson, P., S. Nelson, and R. Dornburg. 1994. Improved self-inactivating retroviral vectors derived from spleen necrosis virus. J. Virol. 68:7060-7066.
20. Osborne, W. R. A. 1991. Retrovirus-mediated gene expression in mammalian cells. Curr. Opin. Biotechnol. 2:708-712.
21. Paulus, W., I. Baur, F. M. Boyce, X. O. Breakefield, and S. A. Reeves. 1996. Self-contained, tetracyclne-regulated retroviral vector system for gene delivery to mammalian cells. J. Virol. 70:62-67.
22. Payne, G. S., J. M. Bishop, and H. E. Varmus. 1982. Multiple arrangements of viral DNA. and an Activated host oncogene in bursal lymphomas. Nature 295:209-214.
23. Salmons, B., and W. H. Günzburg. 1993. Targeting of retroviral vectors for gene therapy. Hum. Gene Ther. 4:129-141.
24. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor Laboratory. Cold Spring Harbor, N.Y.
25. Temin, H. M. 1990. Safety considarations in somatic gene therapy of human disease with retrovirus vectors. Hum. Gene Ther. 1:111-123.
26. Varmus, H., and P. Brown. 1989. Retroviruses. p. 53-108. In D. E. Berg and M. M. Howe (ed.), Mobile DNA. American Society for Microbiology, Washington, D.C.
27. Westaway, D., G. Payne, and H. E. Varmus. 1984. Proviral deletions and oncogene base-substitutions in insertionally mutagenized c-myc alleles may contribute to the progression of avian bursal tumors. Proc. Natl. Acad. Sci. USA 81:843-847.
28. Xu, L., J.-K. Yee, J. A. Wolff. and T. Friedmann. 1989. Factors affecting long-term stability of Moloney murine leukemia virus-based vectors. Virology 171:331-341.
29. Yarranton, G. T. 1992. Inducible vectors for expression in mammalian cells. Curr. Opin. Biotechnol. 3:506-511.
30. Yee, J.-K., J. C. Moores, D. J. Jolly, J. A. Wolff, J. G. Respess, and T. Friedman. 1987. Gene expression from transcriptionally disabled retroviral vectors. Proc. Natl. Acad. Sci. USA 84:5197-5201.
31. Yu, S.-F., T. Rueden, P.W. Kantoff, C. Garber, M. Seiberg, U. Reuther, W. F. Anderson, E. F. Wagner, and E. Gilboa. 1986. Self-inactivating retroviral vectors designed for transfer of whole genes into mammallian cells. Proc. Natl. Acad. Sci. USA 83:3194-3198.